Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy

被引:16
作者
Butler, JC
Lennox, JL
McDougal, LK
Sutcliffe, JA
Tait-Kamradt, A
Tenover, FC
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Arctic Invest Program, Anchorage, AK 99508 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA
[3] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[4] Grady Infect Dis Program, Atlanta, GA USA
[5] Rib X Pharmaceut, New Haven, CT USA
关键词
D O I
10.1086/344965
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Suppurative complications of Streptococcus pneumoniae infections have become uncommon in the antibiotic era. We report a case of pneumococcal bacteremia and pneumonia complicated with epidural abscess and endocarditis in which macrolide resistance (the MLSB, phenotype) emerged during erythromycin therapy. Genetic determinants known to mediate the most common mechanisms of macrolide resistance (methylation of the 23S rRNA and antibiotic efflux) were not detected by polymerase chain reaction or DNA hybridization. Sequence analysis of the DNA encoding the 23S rRNA of the macrolide-resistant isolate from the patient demonstrated the replacement of adenine by thymine at position 2058 (A2058T) in 2 of 4 alleles. Clinicians should be alert to the possibility of the emergence of resistance during macrolide therapy for community-acquired pneumonia, particularly if suppurative complications of pneumococcal infection are suspected.
引用
收藏
页码:E19 / E25
页数:7
相关论文
共 57 条
[1]   Review of pneumococcal endocarditis in adults in the penicillin era [J].
Aronin, SI ;
Mukherjee, SK ;
West, JC ;
Cooney, EL .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :165-171
[2]   PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA [J].
AUSTRIAN, R ;
GOLD, J .
ANNALS OF INTERNAL MEDICINE, 1964, 60 (05) :759-+
[4]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[5]   Infective endocarditis, 1984 through 1993: A clinical and microbiological survey [J].
Benn, M ;
Hagelskjaer, LH ;
Tvede, M .
JOURNAL OF INTERNAL MEDICINE, 1997, 242 (01) :15-22
[6]   Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci [J].
Betriu, C ;
Redondo, M ;
Palau, ML ;
Sánchez, A ;
Gómez, M ;
Culebras, E ;
Boloix, A ;
Picazo, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1838-1841
[7]   The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the centers for disease control and prevention's pneumococcal sentinel surveillance system [J].
Butler, JC ;
Hofmann, J ;
Cetron, MS ;
Elliott, JA ;
Facklam, RR ;
Breiman, RF ;
Camp, C ;
Charache, P ;
Dern, R ;
Jackson, M ;
Hadley, WK ;
HoppeBauer, J ;
Jacobs, MR ;
Schreiber, J ;
Boxerbaum, B ;
Menuey, BC ;
Tyler, PG ;
Monahan, J ;
Moore, H ;
Siegel, JD ;
Sherer, D ;
Rogers, P ;
Welch, D ;
Fine, D ;
Radike, J ;
Fiore, A ;
Alexander, M ;
Deaver, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :986-993
[8]   Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. [J].
Davidson, R ;
Cavalcanti, R ;
Brunton, JL ;
Bast, DJ ;
de Azavedo, JCS ;
Kibsey, P ;
Fleming, C ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) :747-750
[9]  
DIXON JMS, 1967, LANCET, V1, P573
[10]  
DOKTOR S, 2001, 41 INT C ANT AG CHEM, P101